Mechanism of action of and resistance to quinolones
Open Access
- 22 December 2008
- journal article
- review article
- Published by Wiley in Microbial Biotechnology
- Vol. 2 (1), 40-61
- https://doi.org/10.1111/j.1751-7915.2008.00063.x
Abstract
Fluoroquinolones are an important class of wide‐spectrum antibacterial agents. The first quinolone described was nalidixic acid, which showed a narrow spectrum of activity. The evolution of quinolones to more potent molecules was based on changes at positions 1, 6, 7 and 8 of the chemical structure of nalidixic acid. Quinolones inhibit DNA gyrase and topoisomerase IV activities, two enzymes essential for bacteria viability. The acquisition of quinolone resistance is frequently related to (i) chromosomal mutations such as those in the genes encoding the A and B subunits of the protein targets (gyrA, gyrB, parC and parE), or mutations causing reduced drug accumulation, either by a decreased uptake or by an increased efflux, and (ii) quinolone resistance genes associated with plasmids have been also described, i.e. the qnr gene that encodes a pentapeptide, which blocks the action of quinolones on the DNA gyrase and topoisomerase IV; the aac(6′)‐Ib‐cr gene that encodes an acetylase that modifies the amino group of the piperazin ring of the fluoroquinolones and efflux pump encoded by the qepA gene that decreases intracellular drug levels. These plasmid‐mediated mechanisms of resistance confer low levels of resistance but provide a favourable background in which selection of additional chromosomally encoded quinolone resistance mechanisms can occur.Keywords
This publication has 154 references indexed in Scilit:
- Plasmid-Mediated QnrS2 Determinant from a Clinical Aeromonas veronii IsolateAntimicrobial Agents and Chemotherapy, 2008
- ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar TyphimuriumAntimicrobial Agents and Chemotherapy, 2008
- Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from JapanAntimicrobial Agents and Chemotherapy, 2008
- Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with HypermutationAntimicrobial Agents and Chemotherapy, 2007
- Discovery of Novel DNA Gyrase Inhibitors by High-Throughput Virtual ScreeningAntimicrobial Agents and Chemotherapy, 2007
- New Plasmid-Mediated Fluoroquinolone Efflux Pump, QepA, Found in an Escherichia coli Clinical IsolateAntimicrobial Agents and Chemotherapy, 2007
- Role of a qnr -Like Gene in the Intrinsic Resistance of Enterococcus faecalis to FluoroquinolonesAntimicrobial Agents and Chemotherapy, 2007
- Efflux-Related Resistance to Norfloxacin, Dyes, and Biocides in Bloodstream Isolates of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007
- Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other AntimicrobialsAntimicrobial Agents and Chemotherapy, 2007
- Variation of the mexT gene, a regulator of the MexEF-OprN efflux pump expression in wild-type strains of Pseudomonas aeruginosaFEMS Microbiology Letters, 2000